CTLA4 and non-small cell lung carcinoma: Yet, in non-small cell lung cancer (NSCLC) (84) and when expressed in the hepatic hilar region of extrahepatic bile duct cancer patients (85), studies determined that CTLA-4 correlated with improved survival.